Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

30.23
+0.71002.41%
Post-market: 30.400.1700+0.56%19:18 EDT
Volume:1.07M
Turnover:32.03M
Market Cap:2.21B
PE:-128.28
High:30.27
Open:29.38
Low:29.38
Close:29.52
Loading ...
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2023

Correspondence

Form CORRESP - Correspondence
Dec 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Correspondence

Form CORRESP - Correspondence
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Aug 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 01, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 02, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans